Qlaris Bio
Developer of novel therapies designed to treat serious and debilitating ophthalmic diseases. The company's therapies use novel mechanisms of action to potentially serve as an efficacious treatment for...
Valuation
$0
Share Price
N/A
Total Raised
$54.7M
Last Round
N/A